Evidence map›Paper›PMID 34326103›Full record

ArticleAJNR. American journal of neuroradiology2021

Nonstenotic Carotid Plaques in Ischemic Stroke: Analysis of the STRATIS Registry.

N Singh, J Ospel, A Mayank, M Marko, O O Zaidat, N H Mueller-Kronast, D S Liebeskind, M Goyal, STRATIS Investigators

Open access · bronzeAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. The role of non-stenosing carotid artery plaques in embolic stroke of undetermined source, is it a silent offender? A review of literature.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

N SinghFrom the Departments of Clinical Neurosciences (N.S., A.M., M.G.).ORCID 0000-0003-3647-0904
J OspelDepartment of Radiology (J.O.), University Hospital of Basel, Basel, Switzerland.ORCID 0000-0003-0029-6764
A MayankFrom the Departments of Clinical Neurosciences (N.S., A.M., M.G.).
M MarkoDepartment of Neurology (M.M.), Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9063-0465
O O ZaidatNeuroscience Institute (O.O.Z.), Mercy Health St. Vincent Medical Center, Toledo, Ohio.ORCID 0000-0003-4881-4698
N H Mueller-KronastDepartment of Neurology (N.H.M.-K.), Delray Medical Center, Delray Beach, Florida.ORCID 0000-0003-3541-9410
D S LiebeskindUCLA Comprehensive Stroke Center (D.S.L.), Los Angeles, California.ORCID 0000-0002-5109-8736
M GoyalFrom the Departments of Clinical Neurosciences (N.S., A.M., M.G.) mgoyal@ucalgary.ca.ORCID 0000-0001-9060-2109
STRATIS Investigators
Neurosciences Institute · USDelray Medical Center · USMACOM (United States) · USMedical University of Vienna · ATMercy St. Vincent Medical Center · USUCLA Health · USUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeFew studies assess nonstenotic carotid plaques on CTA, and the causative role of these plaques in stroke is not entirely clear. We used CTA to determine the prevalence of nonstenotic carotid plaques (<50%), plaque features, and their association with ipsilateral strokes in patients with cardioembolic and cryptogenic strokes. MATERIALS AND

methodsData were from the Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke (STRATIS) registry, a prospective, nonrandomized registry of patients undergoing thrombectomy with the Solitaire device. The prevalence of nonstenotic carotid plaques ipsilateral and contralateral to the stroke was compared in patients with cryptogenic and cardioembolic strokes. Plaque features were further compared within both subgroups between patients with and without ipsilateral stroke. Adjusted associations among nonstenotic carotid plaque, plaque characteristics, and ipsilateral stroke in both subgroups were determined with logistic regression.

resultsOf the 946 patients in the data base, 226 patients with cardioembolic stroke (median age, 72 years) and 141 patients with cryptogenic stroke (median age, 69 years) were included in the analysis. The prevalence of nonstenotic carotid plaque in the cardioembolic and cryptogenic subgroups was 33/226 (14.6%) and 32/141 (22.7%), respectively. Bilateral nonstenotic carotid plaques were seen in 10/226 (4.4%) patients with cardioembolic and 13/141 (9.2%) with cryptogenic strokes. Nonstenotic carotid plaques were significantly associated with ipsilateral strokes in the cardioembolic stroke (adjusted OR = 1.91; 95% CI, 1.15-3.18) and the cryptogenic stroke (adjusted OR = 1.69; 95% CI, 1.05-2.73) groups. Plaque irregularity, hypodensity, and per-millimeter increase in plaque thickness were significantly associated with ipsilateral stroke in the cryptogenic subgroup.

conclusionsNonstenotic carotid plaques were significantly associated with ipsilateral stroke in cardioembolic and cryptogenic stroke groups, and there was an association of plaque irregularity and hypodense plaque with ipsilateral stroke in the cryptogenic group, suggesting these plaques could be a potential cause of stroke in these patient subgroups.

Indexed as

Brain IschemiaCarotid Artery DiseasesCarotid StenosisIschemic StrokeStrokeAgedHumansProspective StudiesRegistriesRisk Factors

Identifiers

PMID34326103
PMCPMC8423063
OpenAlexW3186740725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.